source Post navigation Health News Roundup: Mask-free Monday comes to Japan as government eases COVID guidelines; Sanofi hones in on type 1 diabetes in $2.9 billion Provention Bio deal and more – Devdiscourse Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for … – GlobeNewswire
